📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. (2022)

First Author: Hammond S

Attributed to: MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/toxsci/kfab144

PubMed Identifier: 34850240

Publication URI: http://europepmc.org/abstract/MED/34850240

Type: Journal Article/Review

Volume: 186

Parent Publication: Toxicological sciences : an official journal of the Society of Toxicology

Issue: 1

ISSN: 1096-0929